Friday, April 30, 2010 9:29:18 AM
""company will be profitable this year, he sees it becoming much more profitable next year and so on- year over year- going forward""
Patrick G. Rooney, the Chariman of the Board of Positron Corporation (OTC:POSC.OB) - a molecular imaging company focused on Nuclear Cardiology- has confirmed in an exclusive interview with BioMedReports that while his company will be profitable this year, he sees it becoming much more profitable next year and so on- year over year- going forward
Patrick G. Rooney, the Chariman of the Board of Positron Corporation (OTC:POSC.OB) - a molecular imaging company focused on Nuclear Cardiology- has confirmed in an exclusive interview with BioMedReports that while his company will be profitable this year, he sees it becoming much more profitable next year and so on- year over year- going forward
Recent POSC News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 06:04:15 PM
- Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices • GlobeNewswire Inc. • 02/17/2026 02:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/30/2025 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2025 03:21:59 PM
- Positron Corporation Announces Its Transition to a Reporting SEC Company • GlobeNewswire Inc. • 11/17/2025 02:19:08 PM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 11/12/2025 10:04:03 PM
- Positron Corporation Enters Industry Partnership Agreement with MedAxiom • GlobeNewswire Inc. • 10/02/2025 01:15:00 PM
- Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025 • GlobeNewswire Inc. • 10/01/2025 01:15:00 PM
